Zoetis (ZTS) Invested Capital (2012 - 2025)

Zoetis (ZTS) posted quarterly Invested Capital of $1.4 billion for Q2 2025, little changed quarter-over-quarter from $1.4 billion in Q1 2025.

Zoetis (ZTS) Invested Capital (2012 - 2025) Analysis & Trends

Zoetis (ZTS) has reported Invested Capital for 12 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2025.

In Q2 2025, Invested Capital changed N/A year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (down 50.0% YoY), while the FY2024 annual figure was $1.4 billion, changed N/A from the prior year.
Invested Capital held at $1.4 billion in Q2 2025 per ZTS's latest filing, from $1.4 billion in the prior quarter.
Across five years, Invested Capital topped out at $1.4 billion in Q1 2022 and bottomed at $2.0 million in Q2 2022.
Historically, Invested Capital has averaged $553.0 million across 5 years, with a median of $312.0 million in 2021.
Annual changes were most pronounced in 2023 — Invested Capital sank 99.78% — and 2025, when it surged 5525.0%.
Zoetis' Invested Capital stood at $600.0 million in 2021, then tumbled by 99.67% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then soared by 67400.0% to $1.4 billion in 2024, then changed by 0.0% to $1.4 billion in 2025.
Business Quant data shows ZTS's Invested Capital at $1.4 billion in Q2 2025, $1.4 billion in Q1 2025, and $1.4 billion in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	43.41 Bn	39.75 Bn	2.15 Bn	4.50 Bn
3	Zoetis	31.83 Bn	30.15 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.77 Bn	22.97 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn	-
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.65 Bn	15.26 Bn	935.80 Mn	-
8	Elanco Animal Health	11.93 Bn	11.40 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-	630.00 Mn
10	Alkermes	8.20 Bn	7.55 Bn	397.90 Mn	26.50 Mn

Download Data